Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells
Yang Feng-Chun, … , Simon J. Atkinson, D. Wade Clapp
Yang Feng-Chun, … , Simon J. Atkinson, D. Wade Clapp
Published December 15, 2003
Citation Information: J Clin Invest. 2003;112(12):1851-1861. https://doi.org/10.1172/JCI19195.
View: Text | PDF
Article Oncology

Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells

  • Text
  • PDF
Abstract

The NF1 tumor suppressor gene encodes a GTPase-activating protein called neurofibromin that negatively regulates Ras signaling. Mutations in NF1 cause neurofibromatosis type 1 (NF1). The development of neurofibromas, which are complex tumors composed of multiple cell types, is a hallmark of NF1. Somatic inactivation of murine Nf1 in Schwann cells is necessary, but not sufficient, to initiate neurofibroma formation. Neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/–) microenvironment. Mast cells infiltrate neurofibromas, where they secrete proteins that can remodel the ECM and initiate angiogenesis. Thus, identification of mechanisms responsible for mast cell migration to tumor microenvironments is important for understanding tumorigenesis and for designing potential therapies. Here, we show that homozygous Nf1 mutant (Nf1–/–) Schwann cells secrete Kit ligand (KitL), which stimulates mast cell migration, and that Nf1+/– mast cells are hypermotile in response to KitL. Furthermore, we link hyperactivation of the Ras-class IA-PI3K-Rac2 pathway to increased Nf1+/– mast cell migration. Thus, these studies identify a novel interaction between Nf1–/– Schwann cells and Nf1+/– mast cells that is likely to be important in neurofibroma formation.

Authors

Yang Feng-Chun, David A. Ingram, Shi Chen, Cynthia M. Hingtgen, Nancy Ratner, Kelly R. Monk, Travis Clegg, Hilary White, Laura Mead, Mary Jo Wenning, David A. Williams, Reuben Kapur, Simon J. Atkinson, D. Wade Clapp

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 2 7 3 3 9 5 7 5 4 5 3 2 4 5 10 5 4 9 5 3 1 1 1 103
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (103)

Title and authors Publication Year
Dysregulated mast cell activation induced by diabetic milieu exacerbates the progression of diabetic peripheral neuropathy in mice
Yao X, Wang X, Zhang R, Kong L, Fan C, Qian Y
Nature Communications 2025
Treatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment.
Hwang JK, Kim SH, Kim DS
Journal of Korean Neurosurgical Society 2025
Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
Helena Mazuelas, Míriam Magallón-Lorenz, Itziar Uriarte-Arrázola, Alejandro Negro, Inma Rosas, Ignacio Blanco, Elisabeth Castellanos, Conxi Lázaro, Bernat Gel, Meritxell Carrió, Eduard Serra
JCI Insight 2024
SOX9 Promotes Collagen VI Secretion by Upregulating PCOLCE in Neurofibroma.
Yao X, Wang B, Su Y, Bing Z, Li Q, Dong Q, Yin H, Wang J, Pan Y, Yuan G
Molecular Neurobiology 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N
Life science alliance 2024
The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation
White EE, Rhodes SD
Cancers 2024
Interactions between Schwann cell and extracellular matrix in peripheral nerve regeneration.
Jiang M, Chen M, Liu N
Frontiers in neurology 2024
NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.
Patritti-Cram J, Rahrmann EP, Rizvi TA, Scheffer KC, Phoenix TN, Largaespada DA, Ratner N
iScience 2024
Unlocking the regenerative key: Targeting stem cell factors for bone renewal
Karima G, Kim HD
Journal of Tissue Engineering 2024
Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas
Armstrong AE, Belzberg AJ, Crawford JR, Hirbe AC, Wang ZJ
BMC Cancer 2023
Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model
McLean DT, Meudt JJ, Lopez Rivera LD, Schomberg DT, Pavelec DM, Duellman TT, Buehler DG, Schwartz PB, Graham M, Lee LM, Graff KD, Reichert JL, Bon-Durant SS, Konsitzke CM, Ronnekleiv-Kelly SM, Shanmuganayagam D, Rubinstein CD
Frontiers in Oncology 2023
Econazole selectively induces cell death in NF1-homozygous mutant tumor cells
Lakes YB, Moye SL, Mo J, Tegtmeyer M, Nehme R, Charlton M, Salinas G, McKay RM, Eggan K, Le LQ
Cell reports. Medicine 2023
Neurofibromin and suppression of tumorigenesis: beyond the GAP
J Mo, S Moye, R McKay, L Le
Oncogene 2022
Current concepts of neurofibromatosis type 1: pathophysiology and treatment.
Choi J, An S, Lim SY
Archives of Craniofacial Surgery 2022
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
Leah J Kershner, Kwangmin Choi, Jianqiang Wu, Xiyuan Zhang, Melissa Perrino, Nathan Salomonis, Jack Shern, Nancy Ratner
JCI Insight 2022
Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development
T Mohamad, C Plante, JP Brosseau
International journal of molecular sciences 2021
Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression
D Sun, XP Xie, X Zhang, Z Wang, SF Sait, SV Iyer, YJ Chen, R Brown, DR Laks, ME Chipman, JF Shern, LF Parada
Cell Stem Cell 2021
Insights into the Pathogenesis of NF1-Associated Neoplasms
A Bui, C Jiang, RM McKay, LJ Klesse, LQ Le
2021
Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing
JP Brosseau, AA Sathe, Y Wang, T Nguyen, DA Glass, C Xing, LQ Le
Acta Neuropathologica Communications 2021
Tumorigenesis in neurofibromatosis type 1: role of the microenvironment
C Jiang, RM McKay, LQ Le
Oncogene 2021
WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth
CS Thomson, J Pundavela, MR Perrino, RA Coover, K Choi, KE Chaney, TA Rizvi, DA Largaespada, N Ratner
Oncogene 2021
The roles of GTPase-activating proteins in regulated cell death and tumor immunity
H He, J Huang, S Wu, S Jiang, L Liang, Y Liu, W Liu, L Xie, Y Tao, Y Jiang, L Cong
Journal of Hematology & Oncology 2021
Cutaneous Findings in Neurofibromatosis Type 1
Ozarslan B, Russo T, Argenziano G, Santoro C, Piccolo V
Cancers 2021
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis in a Pediatric Patient With Neurofibromatosis Type 1
Lehan E, Wang T, Soboleski D, Acker A, Kehar M
ACG Case Reports Journal 2021
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
AE Armstrong, SD Rhodes, A Smith, S Chen, W Bessler, MJ Ferguson, L Jiang, X Li, J Yuan, X Yang, FC Yang, KA Robertson, DA Ingram, JO Blakeley, DW Clapp
Pediatric Blood & Cancer 2020
Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer
HN Vasudevan, CH Lucas, JE Villanueva-Meyer, PV Theodosopoulos, DR Raleigh
Neurosurgery 2020
Neuronal lineages derived from the nerve-associated Schwann cell precursors
P Kameneva, ME Kastriti, I Adameyko
Cellular and Molecular Life Sciences 2020
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST
KE Chaney, MR Perrino, LJ Kershner, AV Patel, J Wu, K Choi, TA Rizvi, E Dombi, S Szabo, DA Largaespada, N Ratner
Cancer research 2020
A narrative review of the role of fibroblasts in the growth and development of neurogenic tumors
Wei CJ, Gu YH, Wang W, Ren JY, Cui XW, Lian X, Liu J, Wang HJ, Gu B, Li QF, Wang ZC
Annals of translational medicine 2020
Cxcr3 expressing leukocytes are necessary for neurofibroma formation in mice
Jonathan Fletcher, Jianqiang Wu, Walter J Jessen, Jay Pundavela, Jacob A. Miller, Eva Dombi, Mi-Ok Kim, Tilat Rizvi, Kashish Chetal, Nathan Salomonis, Nancy Ratner
JCI Insight 2019
Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1
RA de Vasconcelos, PG Coscarelli, TM Vieira, WS Noguera, DC Rapozo, MA Acioly
Cancer Medicine 2019
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
FL Rice, G Houk, JP Wymer, SJ Gosline, J Guinney, J Wu, N Ratner, MP Jankowski, SL Rosa, M Dockum, JR Storey, SL Carroll, PJ Albrecht, VM Riccardi, C Sommer
PloS one 2019
Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside
J Korfhage, DB Lombard
Molecular cancer research : MCR 2019
After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation
JS Fletcher, J Pundavela, N Ratner
2019
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis
CJ Wei, SC Gu, JY Ren, YH Gu, XW Xu, X Chou, X Lian, X Huang, HZ Li, YS Gao, B Gu, T Zan, ZC Wang, QF Li
2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1 -Deficient Mice
CA Burks, SD Rhodes, WK Bessler, S Chen, A Smith, JR Gehlhausen, ET Hawley, L Jiang, X Li, J Yuan, Q Lu, M Jacobsen, GE Sandusky, DR Jones, DW Clapp, JO Blakeley
Molecular cancer therapeutics 2019
Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis
Chung-Ping Liao, Reid Booker, Jean-Philippe Brosseau, Zhiguo Chen, Juan Mo, Edem Tchegnon, Yong Wang, D. Wade Clapp, Lu Le
Journal of Clinical Investigation 2018
Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms:
JF Longo, SM Weber, BP Turner-Ivey, SL Carroll
Advances in Anatomic Pathology 2018
Cutaneous neurofibromas in the genomics era: current understanding and open questions
RJ Allaway, SJ Gosline, SL Rosa, P Knight, A Bakker, J Guinney, LQ Le
British Journal of Cancer 2018
NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
JP Brosseau, CP Liao, Y Wang, V Ramani, T Vandergriff, M Lee, A Patel, K Ariizumi, LQ Le
Nature Communications 2018
The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.
Brosseau JP, Pichard DC, Legius EH, Wolkenstein P, Lavker RM, Blakeley JO, Riccardi VM, Verma SK, Brownell I, Le LQ
Neurology 2018
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
V Staedtke, RY Bai, JO Blakeley
Neurotherapeutics 2017
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors
S Karmakar, KM Reilly
CNS Oncology 2017
An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system
K Choi, K Komurov, JS Fletcher, E Jousma, JA Cancelas, J Wu, N Ratner
Scientific Reports 2017
Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma: BARGAGNA-MOHAN, et al
P Bargagna-Mohan, A Ishii, L Lei, D Sheehy, S Pandit, G Chan, R Bansal, R Mohan
Journal of Neuroscience Research 2017
The role of stem cells in benign tumors
H Qin, D Bao, X Tong, Q Hu, G Sun, X Huang
Tumor Biology 2016
Contextual signaling in cancer
LJ Smithson, C Anastasaki, R Chen, JA Toonen, SB Williams, DH Gutmann
Seminars in Cell & Developmental Biology 2016
The Challenge of Cancer Genomics in Rare Nervous System Neoplasms
SL Carroll
The American Journal of Pathology 2016
Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice
L He, Z Zhu, S Chen, Y Wang, H Gu
Cancer Medicine 2016
Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH
Oncotarget 2016
The New Deal: A Potential Role for Secreted Vesicles in Innate Immunity and Tumor Progression
A Benito-Martin, AD Giannatale, S Ceder, HÃ Peinado
Frontiers in immunology 2015
Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells
Y Zhou, Y He, R Sharma, W Xing, S Estwick, X Wu, S Rhodes, M Xu, FC Yang
International journal of molecular sciences 2015
Preclinical evidence for the use of sunitinib malate in the treatment of plexiform neurofibromas: Sunitinib Malate in Plexiform Neurofibroma Therapy
MJ Ferguson, SD Rhodes, L Jiang, X Li, J Yuan, X Yang, S Zhang, ST Vakili, P Territo, G Hutchins, FC Yang, DA Ingram, DW Clapp, S Chen
Pediatric Blood & Cancer 2015
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
C Stockmann, D Schadendorf, R Klose, I Helfrich
Frontiers in Oncology 2014
Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice
Yan Li, Wen Xing, Yong-Zheng He, Shi Chen, Steven D. Rhodes, Jin Yuan, Yuan Zhou, Jun Shi, Jie Bai, Feng-Kui Zhang, Wei-Ping Yuan, Tao Cheng, Ming-Jiang Xu, Feng-Chun Yang
Stem Cell Investigation 2014
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice
R Sharma, X Wu, SD Rhodes, S Chen, Y He, J Yuan, J Li, X Yang, X Li, L Jiang, ET Kim, DA Stevenson, D Viskochil, M Xu, FC Yang
Human Molecular Genetics 2013
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis
SN Brosius, AN Turk, SJ Byer, NM Brossier, L Kohli, A Whitmire, FM Mikhail, KA Roth, SL Carroll
Acta Neuropathologica 2013
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
SJ Park, B Sawitzki, L Kluwe, VF Mautner, N Holtkamp, A Kurtz
BMC Medicine 2013
FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
S Licciulli, J Maksimoska, C Zhou, S Troutman, S Kota, Q Liu, S Duron, D Campbell, J Chernoff, J Field, R Marmorstein, JL Kissil
2013
Skin-Derived Precursor Cells as an In Vitro Modelling Tool for the Study of Type 1 Neurofibromatosis
A Gutiérrez-Rivera, H Iribar, A Tuneu, A Izeta
Stem Cells International 2012
Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension
K Dahlgaard, A Jung, K Qvortrup, H Clausen, O Kjaerulff, HH Wandall
Proceedings of the National Academy of Sciences 2012
The Plexiform Neurofibroma Microenvironment
FC Yang, K Staser, DW Clapp
Cancer Microenvironment 2012
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
CE Prada, E Jousma, TA Rizvi, J Wu, RS Dunn, DA Mayes, JA Cancelas, E Dombi, MO Kim, BL West, G Bollag, N Ratner
Acta Neuropathologica 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
KA Robertson, G Nalepa, FC Yang, DC Bowers, CY Ho, GD Hutchins, JM Croop, TA Vik, SC Denne, LF Parada, CM Hingtgen, LE Walsh, M Yu, KR Pradhan, MK Edwards-Brown, MD Cohen, JW Fletcher, JB Travers, KW Staser, MW Lee, MR Sherman, CJ Davis, LC Miller, DA Ingram, DW Clapp
The Lancet Oncology 2012
The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1
X Wu, S Chen, Y He, SD Rhodes, KS Mohammad, X Li, X Yang, L Jiang, G Nalepa, P Snider, AG Robling, DW Clapp, SJ Conway, TA Guise, FC Yang
PloS one 2011
Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system
NM Brossier, SL Carroll
Brain Research Bulletin 2011
Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms
SL Carroll
Acta Neuropathologica 2011
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model
W Zhang, SD Rhodes, L Zhao, Y He, Y Zhang, Y Shen, D Yang, X Wu, X Li, X Yang, SJ Park, S Chen, C Turner, FC Yang
Bone 2011
Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially- and Temporally-Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth
GW Simmons, WW Pong, RJ Emnett, CR White, SM Gianino, FJ Rodriguez, DH Gutmann
Journal of Neuropathology and Experimental Neurology 2011
Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation
M Olaopa, H Zhou, P Snider, J Wang, RJ Schwartz, AM Moon, SJ Conway
Developmental Biology 2011
Multiple Increased Osteoclast Functions in Individuals with Neurofibromatosis Type 1
DA Stevenson, J Yan, Y He, H Li, Y Liu, Q Zhang, Y Jing, Z Guo, W Zhang, D Yang, X Wu, H Hanson, X Li, K Staser, DH Viskochil, JC Carey, S Chen, L Miller, K Roberson, L Moyer-Mileur, M Yu, EL Schwarz, M Pasquali, FC Yang
American journal of medical genetics. Part A 2011
The Pathoetiology of Neurofibromatosis 1
EM Jouhilahti, S Peltonen, AM Heape, J Peltonen
The American Journal of Pathology 2011
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression
K Staser, FC Yang, DW Clapp
Annual review of pathology 2011
Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand-dependent mast cell functions
M Chen, S Burgin, K Staser, Y He, X Li, M Robinson, L Jiang, RJ Chan, D Ingram, DW Clapp
Experimental Hematology 2011
Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells
K Staser, FC Yang, DW Clapp
Current Opinion in Hematology 2010
Mast cells and the neurofibroma microenvironment
K Staser, FC Yang, DW Clapp
Blood 2010
Nf1−/− Schwann Cell-Conditioned Medium Modulates Mast Cell Degranulation by c-Kit-Mediated Hyperactivation of Phosphatidylinositol 3-Kinase
S Chen, S Burgin, A McDaniel, X Li, J Yuan, M Chen, W Khalaf, DW Clapp, FC Yang
The American Journal of Pathology 2010
Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer
C Yi, J Maksimoska, R Marmorstein, JL Kissil
Biochemical Pharmacology 2010
Glial Cell Lines: An Overview
De Vries GH, Boullerne AI
Neurochemical Research 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Mice lacking neurofibromin develop gastric hyperplasia
L Lin, J Chen, JA Richardson, LF Parada
American journal of physiology. Gastrointestinal and liver physiology 2009
Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase
F Kweh, M Zheng, E Kurenova, M Wallace, V Golubovskaya, WG Cance
Molecular Carcinogenesis 2009
Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas
LQ Le, T Shipman, DK Burns, LF Parada
Cell Stem Cell 2009
Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve
KR Monk, J Wu, JP Williams, BA Finney, ME Fitzgerald, MD Filippi, N Ratner
Neuron Glia Biology 2008
How does the Schwann cell lineage form tumors in NF1?
SL Carroll, N Ratner
Glia 2008
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
AS McDaniel, JD Allen, SJ Park, ZM Jaffer, EG Michels, SJ Burgin, S Chen, WK Bessler, C Hofmann, DA Ingram, J Chernoff, DW Clapp
Blood 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
FC Yang, DA Ingram, S Chen, Y Zhu, J Yuan, X Li, X Yang, S Knowles, W Horn, Y Li, S Zhang, Y Yang, ST Vakili, M Yu, D Burns, K Robertson, G Hutchins, LF Parada, DW Clapp
Cell 2008
It takes a (dysfunctional) village to raise a tumor
KM Reilly, TV Dyke
Cell 2008
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells
J Wu, JP Williams, TA Rizvi, JJ Kordich, D Witte, D Meijer, AO Stemmer-Rachamimov, JA Cancelas, N Ratner
Cancer Cell 2008
Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life
SJ Morrison, AC Spradling
Cell 2008
Suppression of Proliferation of Two Independent NF1 Malignant Peripheral Nerve Sheath Tumor Cell Lines by the pan-ErbB Inhibitor CI-1033
Dilworth JT, Wojtkowiak JW, Mathieu P, Tainsky MA, Reiners JJ Jr, Mattingly RR, Hancock CN
Cancer biology & therapy 2008
Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.
Bartelt-Kirbach B, Wuepping M, Dodrimont-Lattke M, Kaufmann D
neurogenetics 2008
Angiogenic Expression Profile of Normal and Neurofibromin-Deficient Human Schwann Cells
SL Thomas, GH Vries
Neurochemical Research 2007
Phosphatidylinositol 3-Kinase and Akt Nonautonomously Promote Perineurial Glial Growth in Drosophila Peripheral Nerves
W Lavery, V Hall, JC Yager, A Rottgers, MC Wells, M Stern
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
LQ Le, LF Parada
Oncogene 2007
Molecular Dissection of Isolated Disease Features in Mosaic Neurofibromatosis Type 1
Maertens O, De Schepper S, Vandesompele J, Brems H, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L
The American Journal of Human Genetics 2007
Deletion of Nf1 in Neurons Induces Increased Axon Collateral Branching after Dorsal Root Injury
Romero MI, Lin L, Lush ME, Lei L, Parada LF, Zhu Y
Journal of Neuroscience 2007
Hyperactivation of p21ras and PI3-K cooperate to alter murine and human NF1 haploinsufficient osteoclast functions
Feng-Chun Yang; Shi Chen; Alexander Robling; Xijie Yu; Todd D. Nebesio; Trent Morgan; Xiaohong Li; Jin Yuan; Janet Hock; David A. Ingram; D. Wade Clapp
Journal of Clinical Investigation 2006
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling
FC Yang, S Chen, T Clegg, X Li, T Morgan, SA Estwick, J Yuan, W Khalaf, S Burgin, J Travers, LF Parada, DA Ingram, DW Clapp
Human Molecular Genetics 2006
Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo
LS Haneline, H White, FC Yang, S Chen, C Orschell, R Kapur, DA Ingram
Blood 2006
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis
BC Ling, J Wu, SJ Miller, KR Monk, R Shamekh, TA Rizvi, G Decourten-Myers, KS Vogel, JE DeClue, N Ratner
Cancer Cell 2005
Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.
Hiatt K, Ingram DA, Huddleston H, Spandau DF, Kapur R, Clapp DW
The American Journal of Pathology 2004
It takes two to tango: mast cell and Schwann cell interactions in neurofibromas
DH Viskochil
Journal of Clinical Investigation 2003

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts